longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Abpro Holdings, Inc.

ABPO

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Abpro Holdings, Inc. (ABPO)

Abpro Holdings, Inc., a biotechnology company, focuses on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, oph...

Open
--
High
--
Low
--
Prev. Close
--
Volume
--
Turnover
--
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
--
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market Cap
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
--
Dividend YieldTTM
--
DividendTTM
--
Shares
--
Min lot size
--
Currency
--

News

  • PUBT · Sep 1 at 10:03 AM

    Abpro Holdings chairman Miles Suk resigns, stays on board

  • TradingView · Aug 25 at 09:33 PM

    Miles Suk resigns as CEO of Abpro Holdings; M. Fatih Karatas named Interim CEO

  • PUBT · Aug 14 at 08:11 PM

    Abpro net loss narrows 68% to $940,000 in Q2 FY26; revenue remains no revenue

  • TradingView · Jun 4 at 09:13 PM

    Abpro Holdings Received Notice of Delisting